Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 16 sector : Health technology save search
Radius Health Announces Leadership Appointments
Published: 2022-03-16 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $17.66 -2.75% -2.83% 270K
|
Health Technology
|
| O: 1.15%
H: 3.28%
C: 2.14%
health
Ionis announces publication of positive Phase 2 data for donidalorsen in New England Journal of Medicine
Published: 2022-03-16 (Crawled : 00:00) - prnewswire.com
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: -0.15%
H: 2.62%
C: 2.45%
phase 2 pos positive
BD Announces Cash Tender Offers by Morgan Stanley & Co. LLC
Published: 2022-03-16 (Crawled : 00:00) - prnewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 2.38%
H: 4.42%
C: 4.06%
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: 0.0%
Stealth BioTherapeutics Showcases New Duchenne Muscular Dystrophy Nonclinical Data at the 2022 Muscular Dystrophy Association and Clinical and Scientific Conference
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 3.37%
H: 0.0%
C: -10.28%
muscular dystrophy conference therapeutics duchenne iot
Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 1.28%
H: 3.62%
C: 3.08%
covid-19 day als biopharma conference covid results phase 3
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.23%
H: 3.65%
C: 3.65%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.42%
H: 1.77%
C: 1.48%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 1.42%
H: 7.18%
C: 4.52%
financial results report results
RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2022-03-16 (Crawled : 22:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.72%
H: 0.92%
C: 0.9%
rinvoq treatment fda fda approval approval active ulcerative colitis
Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-16 (Crawled : 21:00) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: -4.17%
H: 9.78%
C: 4.42%
financial results results
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Prevention in combination with the CGuard™ Stent Platform & MicroNet™ Portfolio
Published: 2022-03-16 (Crawled : 21:00) - globenewswire.com
NSPR 4 | $1.91 -8.01% 14K
|
Health Technology
|
| O: -2.69%
H: 12.65%
C: 11.07%
disease stroke one platform
Global Ocular Implants Market Report 2022-2030 Featuring Alcon, Bausch & Lomb, Carl Zeiss, Johnson & Johnson, STAAR Surgical Co, Morcher, Hoya, & Glaukos
Published: 2022-03-16 (Crawled : 21:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
GKOS | $101.1 2.17% 0.0% 350K
|
Health Technology
|
| O: -0.95%
H: 5.33%
C: 4.8%
STAA | $48.28 3.72% 3.48% 750K
|
Health Technology
|
| O: -1.11%
H: 5.36%
C: 4.43%
implant ocular plants report
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-16 (Crawled : 21:00) - globenewswire.com
CPRX | News | $14.73 -2.45% -2.51% 990K
|
Health Technology
|
| O: -5.96%
H: 3.64%
C: -0.4%
als financial results report results
Global Single Cell RNA Sequencing Market Report 2021-2031 Featuring Profiles of 12 Key Players such as 10x Genomics and BD, and 4 Emerging Players such as Biomage and Nucleome Informatics
Published: 2022-03-16 (Crawled : 20:00) - prnewswire.com
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: 0.01%
H: 1.79%
C: 1.72%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.51%
H: 3.15%
C: 3.15%
BIO | $285.28 1.84% 0.0% 230K
|
Health Technology
|
| O: -0.35%
H: 2.61%
C: 2.5%
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: 0.0%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.51%
H: 3.15%
C: 3.15%
PACB | $1.465 -6.09% -6.48% 9.7M
|
Health Technology
|
| O: -0.29%
H: 7.14%
C: 6.84%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.6%
H: 4.58%
C: 4.1%
TXG | $27.56 -0.86% -0.87% 2M
|
Health Technology
|
| O: -0.82%
H: 7.08%
C: 6.67%
genomics genomic leo cel report
Money on the Move: March 9-15
Published: 2022-03-16 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
one
Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
|
| O: 1.41%
H: 2.33%
C: 0.04%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.95%
H: 6.23%
C: 5.19%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
lupus market
Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results
Published: 2022-03-16 (Crawled : 17:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.87%
H: 0.27%
C: -0.51%
pos kidney trial positive results positive results
Ulcerative Colitis Drug Market to Reach $10.59 Billion by 2028: The Brainy Insights
Published: 2022-03-16 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: 2.55%
H: 2.44%
C: 2.35%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
drug ulcerative colitis
Pharmaceutical Packaging Market is Expected to Reach US$ 178.8 Bn 203, at a CAGR of 7.4% Between 2022 And 2031, Says FMI
Published: 2022-03-16 (Crawled : 17:00) - prnewswire.com
WRK | News | $47.1 -2.02% 0.0% 2.1M
|
Process Industries
|
| O: 0.67%
H: 3.34%
C: 2.14%
BERY | $56.37 -0.79% 0.0% 600K
|
Process Industries
|
| O: 1.11%
H: 1.54%
C: 0.24%
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
AMCR | $8.98 -0.55% 0.0% 5.6M
|
Process Industries
|
| O: 0.44%
H: 1.95%
C: 1.51%
Global Digital Dose Inhalers Market to Reach $4.9 Billion by 2026
Published: 2022-03-16 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.01%
H: 2.96%
C: 0.0%
PHG | News | $21.01 1.94% 0.0% 2M
|
Health Technology
|
| O: 0.64%
H: 2.51%
C: 2.2%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
ATR | $140.15 -0.12% 0.0% 420K
|
Process Industries
|
| O: 0.78%
H: 1.18%
C: -0.62%
MMM | $93.0 0.41% -0.4% 3.7M
|
Producer Manufacturing
|
| O: 0.31%
H: 1.04%
C: 0.52%
OPK | $1.245 1.22% 1.2% 2.4M
|
Health Technology
|
| O: 1.51%
H: 3.56%
C: 3.26%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
Global Ophthalmic Lasers Market to Reach $1.2 Billion by 2026
Published: 2022-03-16 (Crawled : 16:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
IEX | $232.27 1.04% 0.0% 380K
|
Producer Manufacturing
|
| O: 0.5%
H: 1.95%
C: 1.29%
IRIX | $2.92 5.9% 21K
|
Health Technology
|
| O: 1.22%
H: 8.19%
C: 3.61%
laser
Biogen Announces Peer-Reviewed Publication of ADUHELM® Phase 3 EMERGE and ENGAGE Data in The Journal of Prevention of Alzheimer’s Disease
Published: 2022-03-16 (Crawled : 16:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 1.96%
H: 1.5%
C: 1.28%
aduhelm alzheimer disease phase 3 merge alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.